Roffman Miller Associates Inc. PA Raises Position in Exponent, Inc. $EXPO

Roffman Miller Associates Inc. PA grew its holdings in Exponent, Inc. (NASDAQ:EXPO) by 0.6% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 312,795 shares of the business services provider’s stock after buying an additional 2,019 shares during the quarter. Exponent comprises about 1.4% of Roffman Miller Associates Inc. PA’s investment portfolio, making the stock its 29th largest holding. Roffman Miller Associates Inc. PA’s holdings in Exponent were worth $23,369,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. DAVENPORT & Co LLC purchased a new stake in Exponent during the 1st quarter worth about $205,000. Principal Financial Group Inc. grew its position in shares of Exponent by 1.0% during the first quarter. Principal Financial Group Inc. now owns 133,498 shares of the business services provider’s stock worth $10,821,000 after buying an additional 1,297 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in Exponent by 2.0% in the first quarter. Envestnet Asset Management Inc. now owns 441,646 shares of the business services provider’s stock valued at $35,800,000 after acquiring an additional 8,501 shares in the last quarter. Alps Advisors Inc. lifted its stake in Exponent by 7.7% in the first quarter. Alps Advisors Inc. now owns 73,182 shares of the business services provider’s stock worth $5,932,000 after acquiring an additional 5,246 shares during the last quarter. Finally, State of Michigan Retirement System lifted its stake in Exponent by 1.7% in the first quarter. State of Michigan Retirement System now owns 12,200 shares of the business services provider’s stock worth $989,000 after acquiring an additional 200 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Exponent presently has a consensus rating of “Hold”.

Exponent Stock Performance

EXPO opened at $72.07 on Tuesday. Exponent, Inc. has a one year low of $63.81 and a one year high of $112.75. The company has a market cap of $3.64 billion, a P/E ratio of 36.04 and a beta of 0.91. The business’s 50-day simple moving average is $69.19 and its 200-day simple moving average is $72.93.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, October 30th. The business services provider reported $0.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. The firm had revenue of $137.07 million during the quarter, compared to the consensus estimate of $131.78 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.50 earnings per share. As a group, analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 19th. Stockholders of record on Friday, December 5th will be issued a $0.30 dividend. The ex-dividend date is Friday, December 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. Exponent’s dividend payout ratio is presently 58.54%.

Exponent announced that its Board of Directors has initiated a share repurchase plan on Thursday, October 30th that permits the company to repurchase $100.00 million in shares. This repurchase authorization permits the business services provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

Insiders Place Their Bets

In other Exponent news, CEO Catherine Corrigan sold 4,930 shares of the company’s stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of $66.82, for a total value of $329,422.60. Following the completion of the transaction, the chief executive officer owned 82,753 shares in the company, valued at $5,529,555.46. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Joseph Sala sold 1,595 shares of Exponent stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,326 shares of company stock worth $1,133,059 over the last ninety days. Insiders own 1.60% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.